NaturalX Health Ventures (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:Berlin

NaturalX Health Ventures is the a €100 million investment vehicle of the Schwabe Group managed by Marvin Amberg, and focused on Series A and Series B investments in the consumer health space.

Average round investment:20.23M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)2023 (1)
Portfolio companies: Switzerland HiloSwitzerland Kyan HealthSwitzerland Mybacs
Mostly invests in: Switzerland Switzerland (3) Health services (3)

3 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to NaturalX Health Ventures

Name Criteria
Germany Beiersdorf
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Competitive Intelligence, Software Services, Biotech
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Amino Capital
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Competitive Intelligence, Software Services
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Japan Itochu Corporation
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Competitive Intelligence, Software Services, Hardware
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Energize Ventures
100%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Competitive Intelligence, Software Services, Hardware
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
France Mutuelles Impact
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Competitive Intelligence, Software Services, Hardware, Pharma
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Blume Equity
99%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Competitive Intelligence, Software Services
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany L&R Ventures
99%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Competitive Intelligence, Software Services, Biotech
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States GreyMatter Capital
99%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Competitive Intelligence, Software Services
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Belgium Gimv
99%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Competitive Intelligence, Software Services, Hardware, Biotech, Pharma
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Germany Team Global
99%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Competitive Intelligence, Software Services, Hardware
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Top